Testosterone patch benefits women with low sexual desire

Aug 14, 2007

Novel research published in the current issue of The Journal of Sexual Medicine supports the claim that women with hypoactive sexual desire disorder or HSDD (persistent or recurrent deficiency and/or absence of sexual fanatasies/thoughts, and/or desire for, or receptivity to, sexual activity, which causes personal distress) show noted improvement in sexual desire and sexual function following low dose testosterone treatment.

Two randomized double-blind, placebo controlled trials in surgically postmenopausal (uterus and ovaries removed) women with HSDD demonstrated that transdermal testosterone patch treatment resulted in significant improvements in the frequency of satisfying sexual activity and sexual desire, as well as a decrease in sexual distress.

A total of 132 participants from the 2 trials were interviewed after a 6-month treatment period regarding their experience with the treatment. Results revealed a significant increase in frequency of satisfying sexual activity and sexual desire based on women experiencing the treatment as beneficial. Those women had an average increase in sexual activity of 4.4 times per 4 weeks. In contrast, women who did not experience a benefit had only a 0.5 increase in activity per 4 weeks.

“More women on testosterone experienced a meaningful benefit (52 percent vs. 31 percent) and, in fact, the odds of experiencing a meaningful benefit on testosterone were 2.4 times greater than that of placebo,” says Sheryl Kingsberg, principal author of the study. Since the women were also able to judge for themselves whether or not the treatment was beneficial, those who experienced benefit were interested in continuing treatment.

“These findings not only confirm the clinical effectiveness of transdermal testosterone, but provide benchmarks for the degree of improvement in sexual function that all future therapies for this disorder should try to attain,” says Jan Shifren, co-author of the study.

"This is an especially relevant clinical study in the field of sexual medicine," said Dr. Irwin Goldstein, Editor-in-Chief of The Journal of Sexual Medicine. "These important data reinforce the positive value that treatment with the low dose testosterone patch can bring to the quality-of-life of surgically post-menopausal women with HSDD."

Source: Blackwell Publishing

Explore further: AbbVie to pay Shire $1.64B fee over nixed merger

add to favorites email to friend print save as pdf

Related Stories

Large testicles are linked to infidelity

Jan 29, 2014

There is a clear correlation between the size of the testicles of male primates and the proneness to infidelity of females. Learn more about sex, sperm and infidelity at the anniversary exhibition Sexus.

Elaborate plumage due to testosterone?

Oct 21, 2011

(PhysOrg.com) -- In many bird species males have a more elaborate plumage than females. This elaborate plumage is often used to signal body condition, to intimidate rivals or to attract potential mates. In ...

Recommended for you

New MCAT shifts focus, will include humanities

11 hours ago

(HealthDay)—The Medical College Admission Test (MCAT) has been revised, and the latest changes, including more humanities such as social sciences, are due to be implemented next April, according to a report ...

Using feminist theory to understand male rape

22 hours ago

Decades of feminist research have framed rape and sexual assault as a 'women's issue', leaving little room for the experiences of male victims. But a new study published in the Journal of Gender Studies suggests that feminist ...

Simulation-based training improves endoscopy execution

Oct 18, 2014

(HealthDay)—Simulation-based training (SBT) improves clinicians' performance of gastrointestinal endoscopy in both test settings and clinical practice, according to research published in the October issue ...

User comments : 0